Hayat Pharmaceutical

Executive Summary

Hayat Pharmaceutical Industries Co. PLC is a Jordan-based manufacturer of branded generic medicines and nutritional supplements, operating a cGMP-compliant, FDA-standard plant. With a broad portfolio spanning 12 therapeutic categories including allergies, cardiovascular, dermatology, and infectious disease, the company serves the MENA region and beyond. Founded in 1994 and publicly listed, Hayat has established a strong domestic brand presence for high-quality, affordable healthcare. As a commercial-stage company, its growth strategy hinges on expanding market share in existing geographies and entering new ones, supported by its robust manufacturing capabilities and diversified product base. While specific financials and pipeline details are not publicly available, Hayat's long track record and compliance with international standards position it as a stable player in the generic pharmaceutical space.

Upcoming Catalysts (preview)

• 2026New product launches in high-demand therapeutic categories70% success
• 2027Expansion into new MENA or African markets via regulatory approvals50% success
• TBDPotential FDA or European GMP certification upgrades enhancing export competitiveness40% success